Butyrolactone I(Synonyms: Olomoucin)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Butyrolactone I (Synonyms: Olomoucin)

Butyrolactone I 是 CDK1 的 ATP 竞争性抑制剂,是 A.terreus 的次级代谢产物。Butyrolactone I 在非小细胞肺癌、小细胞肺癌和前列腺癌细胞系中具有抗肿瘤作用。

Butyrolactone I(Synonyms: Olomoucin)

Butyrolactone I Chemical Structure

CAS No. : 87414-49-1

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Butyrolactone I is an ATP-competitive inhibitor of CDK1 as a secondary metabolite from A. terreus[1]. Butyrolactone I has antitumor effects in non-small cell lung, small cell lung, and prostate cancer cell lines[2].

IC50 & Target

CDK1

 

分子量

424.44

Formula

C24H24O7

CAS 号

87414-49-1

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Nishio K, et al. Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines. Anticancer Res. 1996 Nov-Dec;16(6B):3387-95. P

    [2]. Suzuki M, et al. Butyrolactone I induces cyclin B1 and causes G2/M arrest and skipping of mitosis in human prostate cell lines. Cancer Lett. 1999 Apr 26;138(1-2):121-30.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务